Latest Administration News

Page 95 of 135
EBR Systems has won FDA approval for its pioneering leadless WiSE CRT System, setting the stage for a phased US commercial rollout. The company also secured key Medicare reimbursement pathways and expanded manufacturing capacity, though financial sustainability remains a concern.
Ada Torres
Ada Torres
14 May 2025
Anteris Technologies has submitted its FDA Investigational Device Exemption for the pivotal PARADIGM Trial of its DurAVR heart valve and marked a milestone of 100 patients treated, while expanding manufacturing capacity amid rising R&D costs.
Ada Torres
Ada Torres
14 May 2025
5E Advanced Materials has raised $6.35 million through a private placement to advance its boron and lithium project in Southern California, aiming to strengthen U.S. supply chains and move closer to commercialization.
Maxwell Dee
Maxwell Dee
14 May 2025
News Corporation has updated its financial statements to reflect the sale of Foxtel, reporting a 3% revenue increase in fiscal 2024 driven by its Digital Real Estate Services and Book Publishing segments, alongside a 66% rise in net income from continuing operations.
Elise Vega
Elise Vega
14 May 2025
Sarama Resources Ltd reported a $673,644 net loss for Q1 2025, reflecting ongoing exploration costs and capital raises, while navigating arbitration funding with Burkina Faso authorities.
Maxwell Dee
Maxwell Dee
14 May 2025
US Masters Residential Property Group reported solid Q1 2025 sales of US$48.07 million and a 5% rise in net operating income, while reducing senior debt by over US$31 million despite ongoing market volatility.
Eva Park
Eva Park
13 May 2025
Highfield Resources has obtained a standby loan facility from EMR Capital to support its operations and strategic transaction progress, including advancing its flagship Muga Project. The company also extended the maturity of its convertible loan notes, underscoring ongoing investor confidence during a pivotal phase.
Maxwell Dee
Maxwell Dee
13 May 2025
Neuren Pharmaceuticals has received official FDA minutes confirming the primary endpoints for its pivotal Phase 3 trial of NNZ-2591 targeting Phelan-McDermid syndrome, reinforcing the positive signals from earlier studies.
Ada Torres
Ada Torres
13 May 2025
Life360, Inc. reported a strong Q1 2025 with 32% revenue growth to $103.6 million, driven by a 33% increase in subscription revenue and a return to profitability with $4.4 million net income. The company also advanced its strategic positioning through a $4.5 million acquisition and a key partnership.
Sophie Babbage
Sophie Babbage
13 May 2025
Charter Hall Long WALE REIT has announced a 6.25 cents per stapled security distribution for the quarter ended March 31, 2025, featuring a significant AMIT Fund Payment component. This distribution reflects the REIT’s ongoing commitment to delivering steady income to investors under the Attribution Managed Investment Trust framework.
Eva Park
Eva Park
13 May 2025
Yowie Group intensifies efforts to reclaim a substantial loan from Keybridge Capital, issuing a statutory demand and launching a share placement to shore up finances amid tariff challenges.
Victor Sage
Victor Sage
12 May 2025
PolyNovo has secured Therapeutic Goods Administration clearance for thicker versions of its NovoSorb MTX product, broadening treatment options for complex wounds in Australia.
Ada Torres
Ada Torres
12 May 2025